The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...
Read More
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
Read More 
The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.
Read More 
Director of Graduate Program, Department of Microbiology & Immunology, Stanford University School of Medicine (2002-Present)Member of the Committee on Graduate Studies, Stanford University (2001-2004)Member of School of Medicine Awards Committee, Stanford University School of Medicine (2005-Present)Chair, Dept. of Microbiology & Immunology, Stanford University School of Medicine (2010-2017)
